A placebo-controlled Phase 1/2 trial conducted in East Shanghai has found that administering umbilical cord-derived mesenchymal stem cells reduces frailty in older people. ADVERTISEMENT Stem cells against frailty These researchers begin by defining frailty as “a […]
